UCLA's Jonsson Comprehensive Cancer Center : JCCC Member Directory

Peter Butler, M.D.

Specialty:

Endocrinology

General Information:

Gender:	Male
Language(s):	English

Affiliation(s):

Chief, Department of Medicine, Division of Endocrinology, Diabetes, and Hypertension

Physician, Gonda Diabetes Center, Pituitary Tumor Program

Member, JCCC Cancer and Stem Cell Biology Program Area

Hospital Affiliation(s):

Ronald Reagan UCLA Medical Center

Education:

Fellowship:	Special Clinical Fellow, Endocrinology, Mayo Graduate School of Medicine, 1991 - 1993 Endocrinology Diabetes and Metabolism, Mayo Graduate School of Medicine, 1989 - 1990 Endocrinology, Royal Victoria Infirmary, 1984 - 1987
Residency:	Internal Medicine, Freeman Hospital, 1982 - 1984 Internal Medicine, Western General Hospital, 1981 - 1982
Internship:	Accident Surgery, Birmingham Accident Hospital, 1981 - 1981 Internal Medicine, General Hospital-Birmingham, 1980 - 1981
Medical Degree:	M.D., University of Birmingham, 1980

Contact Information:

Phone:	(310) 206-7312
Email:	pbutler@mednet.ucla.edu
Website:	http://www.lhirc.med.ucla.edu/

Practice Information:

Clinical Interest(s):	Diabetes

Scientific Interest(s):

Dr. Peter Butler is interested in the pathophysiology of islet dysfunction and beta cell apoptosis in diabetes. He also studies the relationship between diabetes and pancreatic cancer, and actions of diabetes medications on pancreatic cancer risk.

Selected Cancer-Related Publications:

Butler PC, Dry S, Elashoff R. GLP-1-based therapy for diabetes: what you do not know can hurt you. Diabetes Care. 2010 Feb;33(2):453-5.

Butler AE, Galasso R, Matveyenko A, Rizza RA, Dry S, Butler PC. Pancreatic duct replication is increased with obesity and type 2 diabetes in humans. Diabetologia. 2010 Jan;53(1):21-6. Epub 2009 Oct 21.

Butler PC. Insulin glargine controversy: a tribute to the editorial team at Diabetologia. Diabetes. 2009 Nov;58(11):2427-8.

Matveyenko AV, Dry S, Cox HI, Moshtaghian A, Gurlo T, Galasso R, Butler AE, Butler PC. Beneficial endocrine but adverse exocrine effects of sitagliptin in the human islet amyloid polypeptide transgenic rat model of type 2 diabetes: interactions with metformin. Diabetes. 2009 Jul;58(7):1604-15. Epub 2009 Apr 29.